Source: Annual Congress 2006 - Clinical management of interstitial lung disease
Disease area: Interstitial lung diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. K. Mazhitova, K. K. Orinbasarova (Almaty, Kazakhstan). Biochemical markers of connective tissue damage at chronic toxic fibrosing alveolitis. Eur Respir J 2006; 28: Suppl. 50, 657

Member's Comments

No comment yet.

Related content which might interest you: Interstitial lung disease with autoimmune features Source: Eur Respir Mon 2011; 54: 104-117 Year: 2011 Occult connective tissue diseases mimicking idiopathic interstitial pneumonias Source: Eur Respir J 2008; 31: 11-20 Year: 2008 Genetic susceptibilty and manifestation of progressive fibrosing interstitial lung diseases. Source: Virtual Congress 2020 – New clinical insights into idiopathic pulmonary fibrosis Year: 2020 Elevated alveolar antioxidant levels in chronic fibrosing interstitial lung diseases Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008 Features of pulmonary involvement in patients with diffuse connective tissue diseases Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Significance of connective tissue disease features in idiopathic interstitial pneumonia Source: Eur Respir J 2012; 39: 661-668 Year: 2012 Novel markers of connective tissue disease in patients with idiopathic interstitial pneumonia Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015 Clinico-radiological profile of connective tissue diseases related interstitial lung diseases Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Source: Eur Respir J 2011; 38: 384-391 Year: 2011 Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities? Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Combined pulmonary emphysema and fibrosis in connective tissue disease Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009 Antifibrotic treatment in progressive non-IPF fibrotic interstitial lung diseases Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia Source: International Congress 2015 – Treatment of IPF Year: 2015 HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders Source: International Congress 2014 – IPF and surroundings Year: 2014 Clinical significance of morphological indexes of inflammation and sclerosis in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 107s Year: 2002 The value of biomarkers in the rheumatoid arthritis related interstitial pneumonia Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 The natural history of progressive fibrosing interstitial lung diseases Source: Eur Respir J, 55 (6) 2000085; 10.1183/13993003.00085-2020 Year: 2020 Markers of fibrosis and tissue destruction in usual interstitial pneumonia associated with pulmonary emphysema Source: Eur Respir J 2007; 30: Suppl. 51, 489s Year: 2007 Genomic comparison of fibrotic rheumatoid arthritis-associated ILD and idiopathic pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015